Cite
HARVARD Citation
Blanco, J. et al. (2015). Impact of Prior Virological Failure and Nucleos(t)ide Genotypic Resistance Mutations on the Efficacy of Switching from Ritonavir-Boosted Protease Inhibitors to Raltegravir. Antiviral therapy. 20 (5), pp. 487-492. [Online].